Home

Mätä kanava kulttuuri medias antitromboticas Matka Eläkkeellä lompakko

Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging  Strategies | Molecular Pharmaceutics
Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging Strategies | Molecular Pharmaceutics

Haris Kamal, MD auf LinkedIn: Antiplatelets and antithrombotics in  neurointerventional procedures:…
Haris Kamal, MD auf LinkedIn: Antiplatelets and antithrombotics in neurointerventional procedures:…

Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and  Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants | Journal  of Medicinal Chemistry
Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants | Journal of Medicinal Chemistry

Woman Putting Antitrombotic Stockings On Stock Photo 392331658 |  Shutterstock
Woman Putting Antitrombotic Stockings On Stock Photo 392331658 | Shutterstock

JCDD | Free Full-Text | Antithrombotic Treatment and Its Association with  Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve  Repair Patients
JCDD | Free Full-Text | Antithrombotic Treatment and Its Association with Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients

Tara Lech on LinkedIn: #anticoagstewardship #pharmacy #pharmacyservices  #ambcarepgy2…
Tara Lech on LinkedIn: #anticoagstewardship #pharmacy #pharmacyservices #ambcarepgy2…

Antithrombotics for secondary prevention of noncardioembolic ischaemic  stroke | Nature Reviews Neurology
Antithrombotics for secondary prevention of noncardioembolic ischaemic stroke | Nature Reviews Neurology

RESTART: REstart or STop Antithrombotics Randomized Trial - REBEL EM -  Emergency Medicine Blog
RESTART: REstart or STop Antithrombotics Randomized Trial - REBEL EM - Emergency Medicine Blog

Antithrombotics: Pathophysiological Rationale for Pharmacological  Interventions | SpringerLink
Antithrombotics: Pathophysiological Rationale for Pharmacological Interventions | SpringerLink

The ACTIV-4b Trial: Antithrombotics For Treatment of Outpatient COVID-19 -  REBEL EM - Emergency Medicine Blog
The ACTIV-4b Trial: Antithrombotics For Treatment of Outpatient COVID-19 - REBEL EM - Emergency Medicine Blog

Pharmacy | Free Full-Text | Practical Guide for Anticoagulant and  Antiplatelet Reversal in Clinical Practice
Pharmacy | Free Full-Text | Practical Guide for Anticoagulant and Antiplatelet Reversal in Clinical Practice

Impact of different antithrombotics on the microcirculation and viability  of perforator-based ischaemic skin flaps in a small animal model |  Scientific Reports
Impact of different antithrombotics on the microcirculation and viability of perforator-based ischaemic skin flaps in a small animal model | Scientific Reports

Antithrombotic Medication Use and Bleeding Risk in Medically Ill Patients  After Hospitalization - Charles E. Mahan, Alex C. Spyropoulos, Maxine D.  Fisher, Larry E. Fields, Roger M. Mills, Judith J. Stephenson, An-Chen
Antithrombotic Medication Use and Bleeding Risk in Medically Ill Patients After Hospitalization - Charles E. Mahan, Alex C. Spyropoulos, Maxine D. Fisher, Larry E. Fields, Roger M. Mills, Judith J. Stephenson, An-Chen

Direct Oral Anticoagulants and Coronary Artery Disease | Arteriosclerosis,  Thrombosis, and Vascular Biology
Direct Oral Anticoagulants and Coronary Artery Disease | Arteriosclerosis, Thrombosis, and Vascular Biology

Guidelines | SCCM
Guidelines | SCCM

Marine Drugs | Free Full-Text | Marine Antithrombotics
Marine Drugs | Free Full-Text | Marine Antithrombotics

Frontiers | Antiplatelet Therapy for Atherothrombotic Disease in 2022—From  Population to Patient-Centered Approaches
Frontiers | Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches

IJERPH | Free Full-Text | Multiple Medication Adherence and Related  Outcomes in Community-Dwelling Older People on Chronic Polypharmacy: A  Retrospective Cohort Study on Administrative Claims Data
IJERPH | Free Full-Text | Multiple Medication Adherence and Related Outcomes in Community-Dwelling Older People on Chronic Polypharmacy: A Retrospective Cohort Study on Administrative Claims Data

Antithrombotics in ACS—moving beyond unfractionated heparin | Nature  Reviews Cardiology
Antithrombotics in ACS—moving beyond unfractionated heparin | Nature Reviews Cardiology

Antiplatelet | CFR Journal
Antiplatelet | CFR Journal

Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic  Stroke With Aspirin Treatment Failure | Stroke
Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure | Stroke

Factor XI(a): a potential new option in anti-thrombotic therapy? | Bayer  Global
Factor XI(a): a potential new option in anti-thrombotic therapy? | Bayer Global

Piericones A and B as Potent Antithrombotics: Nanomolar Noncompetitive  Protein Disulfide Isomerase Inhibitors with an Unexpected Chemical  Architecture | Journal of the American Chemical Society
Piericones A and B as Potent Antithrombotics: Nanomolar Noncompetitive Protein Disulfide Isomerase Inhibitors with an Unexpected Chemical Architecture | Journal of the American Chemical Society

JCDD | Free Full-Text | Novel Antithrombotic Agents in Ischemic  Cardiovascular Disease: Progress in the Search for the Optimal Treatment
JCDD | Free Full-Text | Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment

Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet  Agents | Circulation Research
Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents | Circulation Research